Back to search
FDAFDA · Food and drugs·Recall number D-0693-2026

TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.

Published July 8, 2026 · Recall initiated: April 8, 2026

Summary

FDA records drug Class II recall D-0693-2026, published July 8, 2026 and initiated April 8, 2026. Recalling firm: Blaine Labs Inc; Status: Ongoing; Reported quantity: 519 - 1 oz bottles; Lot: Lot #: BL3435, Exp. 11/06/26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated

What to do

Voluntary: Firm initiated · Press Release

Get an email if TRIDERGEL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TRIDERGEL
Manufacturer
Blaine Labs Inc
Distributor
Nationwide in the USA
Lot
Lot #: BL3435, Exp. 11/06/26
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01. recalled?

Yes. FDA published recall D-0693-2026 on July 8, 2026. Reported hazard: CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TRIDERGEL.